Close

Gilead Sciences (GILD) Announces Results from Studies of Switching HIV-1 Patients to Descovy; Results Statistically non-Inferior

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. META
5. BA
6. SPOT
7. V
8. IBM
9. KMB
10. HCP


Go back to Gilead Sciences (GILD) Announces Results from Studies of Switching HIV-1 Patients to Descovy; Results Statistically non-Inferior
Gilead Sciences (NASDAQ: GILD) Delayed: 67.08 +0.05 (0.07%)
Previous Close $67.03    52 Week High $108.63 
Open $66.58    52 Week Low $71.39 
Day High $67.19    P/E 37.06 
Day Low $66.37    EPS $1.81 
Volume 8,491,027